copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Antiphospholipid syndrome: Diagnosis - UpToDate Antiphospholipid syndrome (APS) is a clinical and laboratory diagnosis characterized by both persistent laboratory evidence of antiphospholipid antibodies (aPL) and related complications, which may include venous thrombosis, arterial thrombosis, adverse pregnancy outcomes, and nonthrombotic manifestations (eg, heart valve thickening, livedo reti
Positive antiphospholipid antibodies: observation or treatment? Antiphospholipid antibodies (APLAs) are primarily directed toward phospholipid-binding proteins and are responsible for thrombotic events APLAs include anti-β2Glycoprotein I (anti-β2GPI), anticardiolipin (anti-CL) antibodies, and lupus anticoagulant
Aplas - An atlas for application landscapes Aplas provides us with visibility across our entire IT Portfolio using a language that reduces complexity and risk of our SaaS and traditional IT investments With this tool we can describe how our platform works to business, IT security and risk teams
Antiphospholipid Antibodies | Circulation Antiphospholipid antibodies (APLAs) are proteins that may be present in the blood and may increase your risk for blood clots or pregnancy losses If you have a history of blood clots or recurrent pregnancy losses, you may have been tested for the presence of APLAs in your blood
Anti-Phospholipid Antibody Syndrome — RheumInfo Anti-phospholipid antibody syndrome (APLAS) is an autoimmune disease that causes the body to mount an attack against itself The immune systems of people with Anti-phospholipid antibody syndrome produce antibodies called anti-phospholipid antibodies
ANTIPHOSPHOLIPID ANTIBODY SYNDROME (APLAS) APLAS is characterized by the production of auto-antibodies against protein epitopes which form complexes with negatively charged phospholipids in cell membranes (1)
Antiphospholipid Antibodies Many studies show that APLAs can be associated with a variety of other clin-ical findings, including low platelets, anemia, heart valve disease, skin rashes, mini-strokes, joint pain, joint inflammation, dry eyes, and dry mouth
Analysis of Antiphospholipid Antibody Syndrome (APLA) Diagnosis and . . . Accurate identification and understanding of patient demographics, comorbidities, and outcomes are crucial for effective management of APLA This study aims to identify the prevalence of APLA in hospitalized patients and analyze associated demographic factors, comorbidities, and healthcare outcomes Methods: